Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProShares Ultra Nasdaq Biotechnology (NQ:BIB)

68.84 +1.86 (+2.78%)
Streaming Delayed Price Updated: 2:16 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,583
Open 68.71
Bid (Size) 68.80 (1)
Ask (Size) 68.96 (2)
Prev. Close 66.98
Today's Range 67.87 - 68.95
52wk Range 33.77 - 69.23
Shares Outstanding N/A
Dividend Yield 1.05%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally
Wedbush’s new price target implies a whopping 730% potential upside to the stock’s closing price on Thursday. 
Via Stocktwits
Pharma Tariffs Back In Spotlight On New Trump Threat
President Donald Trump threatened 100% tariffs on some drug imports. 
Via Investor's Business Daily
Topics ETFs Government World Trade

Performance

YTD
+34.1%
+34.1%
1 Month
+20.6%
+20.6%
3 Month
+34.1%
+34.1%
6 Month
+50.1%
+50.1%
1 Year
+9.0%
+9.0%

More News

Read More
Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn
Via Investor's Business Daily
Topics ETFs Government World Trade
Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs
Via Investor's Business Daily
Topics ETFs Economy Government
Friday Trades And June Summary
Via Talk Markets
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals
Via Stocktwits
Topics Bankruptcy
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility
Via Stocktwits
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding
Via Stocktwits
Amgen, Inc. Dividend Stock Analysis
Via Talk Markets
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Via InvestorPlace
The 7 Best ETFs to Buy to Cover 2023’s Biggest Investing Opportunities
Via InvestorPlace
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Via InvestorPlace
Market Briefing For Tuesday, July 5, 2022
Via Talk Markets
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Via Benzinga
Take A Look At The Top-Performing Biotech ETFs YTD
Via Talk Markets

Frequently Asked Questions

Is ProShares Ultra Nasdaq Biotechnology publicly traded?
Yes, ProShares Ultra Nasdaq Biotechnology is publicly traded.
What exchange does ProShares Ultra Nasdaq Biotechnology trade on?
ProShares Ultra Nasdaq Biotechnology trades on the Nasdaq Stock Market
What is the ticker symbol for ProShares Ultra Nasdaq Biotechnology?
The ticker symbol for ProShares Ultra Nasdaq Biotechnology is BIB on the Nasdaq Stock Market
What is the current price of ProShares Ultra Nasdaq Biotechnology?
The current price of ProShares Ultra Nasdaq Biotechnology is 68.84
When was ProShares Ultra Nasdaq Biotechnology last traded?
The last trade of ProShares Ultra Nasdaq Biotechnology was at 10/27/25 02:16 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.